Back to PRICE T ROWE ASSOCIATES INC /MD/ PRICE T ROWE ASSOCIATES INC /MD/

AURAAURA
15 quarters

Position history for PRICE T ROWE ASSOCIATES INC /MD/PRICE T ROWE ASSOCIATES INC /MD/'s holdings in AURA BIOSCIENCES INC

Yes. Price T Rowe Associates holds 278,471 shares of AURA (Aura Biosciences), worth $2M, as of its Q2 2026 13F filing. It reduced the position by 136,720 shares (-32.9%) from Q1 2026. Price T Rowe Associates has held AURA since Q4 2022, across 15 quarterly 13F filings.

Current Value

$2M

Current Shares

278,471

Total Value Change

-$5.8M

Total Shares Change

-460,744

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
278,471
-32.9%
$2M0.0%$7.10
0
2026-Q1
Decreased
415,191
-6.2%
$2.8M0.0%$6.24
0
2025-Q4
Decreased
442,789
-8.0%
$2.4M0.0%$5.49
0
2025-Q3
Decreased
481,231
-4.7%
$3M0.0%$6.17
0
2025-Q2
Decreased
504,828
-2.9%
$3.2M0.0%$6.28
0
2025-Q1
Decreased
519,785
-6.7%
$3M0.0%$6.34
0
2024-Q4
Increased
556,941
+7.9%
$4.6M0.0%$8.13
29
2024-Q3
Decreased
516,126
-10.0%
$4.6M0.0%$9.03
0
2024-Q2
Decreased
573,640
-3.7%
$4.3M0.0%$7.56
0
2024-Q1
Decreased
595,540
-9.7%
$4.7M0.0%$7.85
0
2023-Q4
Increased
659,692
+0.4%
$5.8M0.0%$8.86
27
2023-Q3
Decreased
657,029
-1.3%
$5.9M0.0%$8.97
0
2023-Q2
Decreased
665,528
-6.3%
$8.2M0.0%$12.31
0
2023-Q1
Decreased
710,605
-3.9%
$6.6M0.0%$8.88
0
2022-Q4
New
739,215
-
$7.8M0.0%$10.50
38

Other major holders of AURA: CITADEL ADVISORS LLC, ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used